Pulmonary exacerbations and cystic fibrosis

NACFC 2024 | W38: Epidemiology and Management of Infection in CFПодробнее

Effect of an Exercise Rehabilitation Program on Cystic Fibrosis Adult PatientsПодробнее

"exploring cystic fibrosis: clinical manifestations of pulmonary disease"Подробнее

" Cystic Fibrosis Case 4: Cause of Early Respiratory Symptoms"Подробнее

"exploring cystic fibrosis: clinical manifestations of pulmonary disease in pediatrics"Подробнее

Advances in Reducing Respiratory Events From Cystic Fibrosis with Greg Duncan CeltaxsysПодробнее

DOM Grand Rounds: The Changing Face of Cystic FibrosisПодробнее

Effect of an Exercise Rehabilitation Program on Cystic Fibrosis Adult PatientsПодробнее

mangement of exacerbation of cystic fibrosisПодробнее

NACFC 2023 | S02: Year's in ReviewПодробнее

NACFC 2022 | W01: PEx in the Era of Highly Effective Modulator Therapy (HEMT):How Do We Define This?Подробнее

Cystic fibrosisПодробнее

RESPIRATORY PRIORITIZATION AND COMMON SENSEПодробнее

NACFC 2023 | W30: Management of CF Pulmonary InfectionsПодробнее

NACFC 2023 | W14: Lung Health in a Changing WorldПодробнее

NACFC 2023 | S20: Impact of Polymicrobial Interactions on Antimicrobial Resistance & Virulence in CFПодробнее

Anti-protease levels in CF: lung function, recovery from pulmonary exacerbations & genderПодробнее

Improving Time to Diagnosis of Non-Cystic Fibrosis Bronchiectasis:Fulfilling Unmet Needs of PatientsПодробнее

NACFC 2023 | S05: Emerging Topics in CF Lung DiseaseПодробнее

NACFC 2023 | S29: Social and Environmental Impacts on CF Health OutcomesПодробнее